These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22083667)

  • 1. Peripheral assessment of the genes AQP4, PBP and TH in patients with Parkinson's disease.
    Thenral ST; Vanisree AJ
    Neurochem Res; 2012 Mar; 37(3):512-5. PubMed ID: 22083667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporin-4 deficiency reduces TGF-β1 in mouse midbrains and exacerbates pathology in experimental Parkinson's disease.
    Xue X; Zhang W; Zhu J; Chen X; Zhou S; Xu Z; Hu G; Su C
    J Cell Mol Med; 2019 Apr; 23(4):2568-2582. PubMed ID: 30680924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative pathology and AQP4 mRNA expression in patients of Parkinson's disease in Tamil Nadu.
    Subburaman TT; Vanisree AJ
    Ann Neurosci; 2011 Jul; 18(3):109-12. PubMed ID: 25205934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease.
    Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
    Mov Disord; 1994 May; 9(3):337-9. PubMed ID: 7913740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Aquaporin 1 and Aquaporin 4 in the Temporal Neocortex of Patients with Parkinson's Disease.
    Hoshi A; Tsunoda A; Tada M; Nishizawa M; Ugawa Y; Kakita A
    Brain Pathol; 2017 Mar; 27(2):160-168. PubMed ID: 26919570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency of GCH1 and TH mutations in Parkinson's disease.
    Rengmark A; Pihlstrøm L; Linder J; Forsgren L; Toft M
    Parkinsonism Relat Disord; 2016 Aug; 29():109-11. PubMed ID: 27185167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
    Wang X; Yang HA; Wang XN; Du YF
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human tyrosine hydroxylase in Parkinson's disease and in related disorders.
    Nagatsu T; Nakashima A; Ichinose H; Kobayashi K
    J Neural Transm (Vienna); 2019 Apr; 126(4):397-409. PubMed ID: 29995172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of tyrosine hydroxylase mRNA in a sub-population of A10 dopamine neurons in Parkinson's disease.
    Tong ZY; Kingsbury AE; Foster OJ
    Brain Res Mol Brain Res; 2000 Jun; 79(1-2):45-54. PubMed ID: 10925142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.
    Kastner A; Hirsch EC; Agid Y; Javoy-Agid F
    Brain Res; 1993 Mar; 606(2):341-5. PubMed ID: 8098254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of tyrosine hydroxylase in management of Parkinson's disease.
    Feve AP
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):450-5. PubMed ID: 22583428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin 4: A key player in Parkinson's disease.
    Tamtaji OR; Behnam M; Pourattar MA; Jafarpour H; Asemi Z
    J Cell Physiol; 2019 Dec; 234(12):21471-21478. PubMed ID: 31127615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.
    McMillan PJ; White SS; Franklin A; Greenup JL; Leverenz JB; Raskind MA; Szot P
    Brain Res; 2011 Feb; 1373():240-52. PubMed ID: 21147074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.
    Sun H; Liang R; Yang B; Zhou Y; Liu M; Fang F; Ding J; Fan Y; Hu G
    Neuroscience; 2016 Mar; 317():65-75. PubMed ID: 26774050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson's disease.
    Kunugi H; Kawada Y; Hattori M; Ueki A; Otsuka M; Nanko S
    Am J Med Genet; 1998 Mar; 81(2):131-3. PubMed ID: 9613851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects.
    Nagatsu T; Sawada M
    J Neural Transm Suppl; 2007; (72):113-20. PubMed ID: 17982884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis of Parkinson's disease, a molecular genetic approach].
    Kaneda N; Nagatsu T
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1510-3. PubMed ID: 2576527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.